Broadening indications for neoadjuvant immunotherapy
Br J Dermatol
.
2020 Sep;183(3):421-422.
doi: 10.1111/bjd.18873.
Epub 2020 Feb 3.
Authors
S A Blankenstein
1
,
A C J van Akkooi
1
Affiliation
1
Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.
PMID:
32017031
DOI:
10.1111/bjd.18873
No abstract available
Publication types
Comment
MeSH terms
Humans
Immunotherapy
Ipilimumab
Melanoma* / drug therapy
Neoadjuvant Therapy*
Nivolumab
Substances
Ipilimumab
Nivolumab